Carrie McKim
Director of Investor Relations
Replay available
Codexis, Inc. (NASDAQ: CDXS) Q1 2025 earnings conference call, held 2025-05-14. Replay captured from the company's public earnings webcast.

Director of Investor Relations
Chairman and Chief Executive Officer
Chief Financial Officer
Senior Vice President of Research
Analyst, Cancer for Show
Analyst, Jefferies
Analyst, Piper Sandler
Analyst, Steeple
Analyst, Craig Callum
Analyst, TD Cal
Greetings and welcome to the Codex's first quarter 2025 earnings conference call and webcast. At this time, all participants are in listen-only mode. If anyone should require operator assistance, please press star zero on your telephone keypad. A question and answer session will follow the formal presentation. You may be placed into question queue at any time by pressing star one on your telephone keypad. And in the interest of time, we ask you please limit yourselves to one question. As a reminder, This conference is being recorded. It's now my pleasure to turn the call over to your host, Carrie McKim, Director of Investor Relations. Carrie, please go ahead. Thank you, Operator. With me today are Dr. Stephen Dilley, Codexys Chairman and Chief Executive Officer, Georgia Herbez, Chief Financial Officer, and Dr. Stefan Lutz, Senior Vice President of Research. During this call, management will be making a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including our guidance for 2025 revenue, anticipated milestones, including product launches, pilot scale manufacturing, and paths to scale-up, technical milestones, and public announcements related thereto, as well as our strategies and prospects for revenue growth, paths to profitability, and successful execution of current and future programs and partnerships. To the extent that statements contained in this call are not descriptions of historical facts regarding Codexys, they are forward-looking statements reflecting the beliefs and expectations of management as of the statement date, May 14, 2025. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors that are,...